MasterClass: Volition Reignition: Achieving Patient Goals by Detecting and Addressing Anhedonia in MDD
90 min
Thursday, September 17, 2026
10:15 AM - 11:45 AM
Anhedonia remains one of the most disabling and difficult-to-treat features of major depressive disorder. This session reviews the evolving understanding of reward system dysfunction, explores practical methods for identifying and assessing anhedonia, and evaluates emerging therapies designed to improve meaningful recovery and patient-centered outcomes.
Supported by an educational grant from Axsome Therapeutics Inc.
Supported by an educational grant from Axsome Therapeutics Inc.
-
Speaker
-
Brittany Albright MD, MPH -
-
-
Room
- Great Hall D